Nevertheless, we establish that LILRB1 corresponds with immune infiltration in glioma and may be an oncogene and connects with immune infiltration in glioma and may be a therapeutic strategy and prognostic indicator for glioma. The gene discussed is LILRB1; the disease is central nervous system cancer.